Role of peroxisome proliferator-activated receptor (PPAR) agonists in experimental liver fibrosis in rats

被引：0
|
作者：
Ghoneim, MT [1 ]
El-Azim, TA [1 ]
Baraka, AM [1 ]
Matta, MM [1 ]
El-Din, NMN [1 ]
机构：
[1] Univ Alexandria, Fac Med, Dept Pharmacol, El Messalla 21521, Egypt
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2005年 / 371卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
374
引用
收藏
页码：R89 / R89
页数：1
相关论文
共 50 条
  • [21] The role of peroxisome proliferator-activated receptorδ (PPARδ) in the process of implantation in the mink
    Desmarais, J
    Bennett, RD
    Gévry, N
    Murphy, BD
    BIOLOGY OF REPRODUCTION, 2002, 66 : 123 - 123
  • [22] Evidence for peroxisome proliferator-activated receptor (PPAR)α-independent peroxisome proliferation:: Effects of PPARγ/δ-specific agonists in PPARα-Null mice
    DeLuca, JG
    Doebber, TW
    Kelly, LJ
    Kemp, RK
    Molon-Noblot, S
    Sahoo, SP
    Ventre, J
    Wu, MS
    Peters, JM
    Gonzalez, FJ
    Moller, DE
    MOLECULAR PHARMACOLOGY, 2000, 58 (03) : 470 - 476
  • [23] Natural product agonists of peroxisome proliferator-activated receptor gamma (PPAR-γ): a review
    Wang, Limei
    Waltenberger, Birgit
    Pferschy-Wenzig, Eva-Maria
    Blunder, Martina
    Liu, Xin
    Malainer, Clemens
    Blazevic, Tina
    Schwaiger, Stefan
    Rollinger, Judith M.
    Heiss, Elke H.
    Schuster, Daniela
    Kopp, Brigitte
    Bauer, Rudolf
    Stuppner, Hermann
    Dirsch, Verena M.
    Atanasov, Atanas G.
    BIOCHEMICAL PHARMACOLOGY, 2014, 92 (01) : 73 - 89
  • [24] Role of NSAIDs and peroxisome proliferator-activated receptor γ-agonists on APP processing
    Sastre, M
    Freihoff, D
    Klockgether, T
    Heneka, MT
    Landreth, G
    Gavrilyuk, V
    Feinstein, DL
    Bayer, TA
    Gandy, S
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S223 - S224
  • [25] Peroxisome proliferator-activated receptor (PPAR) agonists as a potential therapy for inherited metabolic disorders
    Seminotti, Bianca
    Grings, Mateus
    Vockley, Jerry
    Leipnitz, Guilhian
    BIOCHEMICAL PHARMACOLOGY, 2023, 209
  • [26] Blocking the Peroxisome Proliferator-Activated Receptor (PPAR): An Overview
    Ammazzalorso, Alessandra
    De Filippis, Barbara
    Giampietro, Letizia
    Amoroso, Rosa
    CHEMMEDCHEM, 2013, 8 (10) : 1609 - 1616
  • [27] Peroxisome proliferator-activated receptor (PPAR) α and γ agonists directly bind and close KATP channel
    Shimomura, K
    Shimizu, H
    Ikeda, M
    Matsumoto, S
    Mori, M
    DIABETES, 2003, 52 : A369 - A369
  • [28] Peroxisome proliferator-activated receptor γ (PPARγ) and colorectal carcinogenesis
    Ioannis A. Voutsadakis
    Journal of Cancer Research and Clinical Oncology, 2007, 133 : 917 - 928
  • [29] Peroxisome proliferator-activated receptor γ (PPARγ) and colorectal carcinogenesis
    Voutsadakis, Ioannis A.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2007, 133 (12) : 917 - 928
  • [30] Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist
    Iwaisako, Keiko
    Haimerl, Michael
    Paik, Yong-Han
    Taura, Kojiro
    Kodama, Yuzo
    Sirlin, Claude
    Yu, Elizabeth
    Yu, Ruth T.
    Downes, Michael
    Evans, Ronald M.
    Brenner, David A.
    Schnabl, Bernd
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (21) : E1369 - E1376
12345